Health Care & Life Sciences » Pharmaceuticals | Kissei Pharmaceutical Co. Ltd.

Kissei Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
70,399
70,110
71,294
71,707
73,998
72,302
Cost of Goods Sold (COGS) incl. D&A
23,855
24,694
24,193
25,771
26,662
27,644
Gross Income
46,544
45,416
47,101
45,936
47,336
44,658
SG&A Expense
34,244
37,080
36,636
37,256
37,259
38,288
EBIT
12,301
8,334
10,274
8,491
9,888
6,204
Unusual Expense
147
706
58
67
387
225
Non Operating Income/Expense
910
1,376
880
1,538
1,412
1,133
Interest Expense
36
33
31
24
23
23
Pretax Income
13,400
10,466
11,136
10,116
11,697
7,121
Income Tax
4,284
3,278
2,941
2,351
2,598
1,586
Consolidated Net Income
9,116
7,188
8,195
7,765
9,098
5,535
Net Income
9,093
7,165
8,165
7,726
9,046
5,481
Net Income After Extraordinaries
9,093
7,165
8,165
7,726
9,046
5,481
Net Income Available to Common
9,093
7,165
8,165
7,726
9,045
5,481
EPS (Basic)
176.66
142.13
166.88
158.73
188.24
117.33
Basic Shares Outstanding
51
50
49
49
48
47
EPS (Diluted)
176.66
142.13
166.88
158.73
188.24
117.33
Diluted Shares Outstanding
51
50
49
49
48
47
EBITDA
14,491
10,537
12,617
10,861
12,380
8,811
Other Operating Expense
1
2
191
189
189
166
Non-Operating Interest Income
78
83
71
46
33
35
Minority Interest Expense
23
23
30
39
52
54

About Kissei Pharmaceutical Co.

View Profile
Address
19-48 Yoshino
Matsumoto 399
Japan
Employees -
Website http://www.kissei.co.jp
Updated 07/08/2019
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Ethical Pharmaceuticals and Others. The Ethical Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism.